Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancer.
about
Prognostic importance of single-nucleotide polymorphisms in IL-6, IL-10, TGF-β1, IFN-γ, and TNF-α genes in chronic phase chronic myeloid leukemia.Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy.The associations between immunity-related genes and breast cancer prognosis in Korean women.Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the Breast Cancer Health Disparities Study.IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer.Antagonistic pleiotropy at the human IL6 promoter confers genetic resilience to the pro-inflammatory effects of adverse social conditions in adolescence.Cytokine genetic variations and fatigue among patients with breast cancer.PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy.Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.Preliminary evidence of an association between an interleukin 6 promoter polymorphism and self-reported attentional function in oncology patients and their family caregivers.The role of intratumoral and systemic IL-6 in breast cancer.Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer.IL-6 variant is associated with metastasis in breast cancer patients.Obesity-associated Breast Cancer: Analysis of risk factors.Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications.Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer.Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer.Education, tobacco smoking, alcohol consumption, and IL-2 and IL-6 gene polymorphisms in the survival of head and neck cancer
P2860
Q33705658-EDDF1DD5-0C18-46DD-B3AB-A9448770C18FQ33714950-7F0DFE0F-FC4C-4700-BAAE-C1311C8091D9Q33975510-CB068F0F-7800-4407-8C96-5518AEF51818Q34009975-944E93C6-C806-4995-8AD4-3FA4175C4A6BQ34346672-645BF39D-35FF-4768-B4B4-65DA70C8590FQ36557683-63E067D9-2631-4EC5-AA0C-FC64B2EF9CBCQ36670040-01374CB6-6C6E-4DB3-9CCB-C5BD222EC23FQ36793285-5C4801D6-4FF2-43D2-8E44-DA60387D7799Q36903206-5516BC87-2673-4ECB-979F-7DAF21C2B084Q37688991-5E57E453-C709-406E-B7B3-344AE4A243CCQ37730169-FB7E1EF3-4990-4AE0-8184-97EFDECF3A6CQ38093468-FF33BB46-04FA-45DC-9425-CF16333C07A9Q38678484-6F244799-DBC3-45AD-807B-8840517F961AQ41090566-6F9B5811-D1C6-47D1-AAB1-81E18403DAC9Q50957755-D59E0488-7907-48DB-8C9C-1A16DAEE4BF7Q51382532-F968B355-F0E9-42AF-9F50-60216745A9B9Q53150503-520EA72B-D83C-4985-9914-F7A5C0CDD251Q53279443-76424E44-8D1F-4C6E-BF61-3507E3F9B53FQ58857134-2DA8DDC0-1694-472E-B706-AE603B487DDA
P2860
Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Host genetic variants in the i ...... , node-positive breast cancer.
@ast
Host genetic variants in the i ...... , node-positive breast cancer.
@en
type
label
Host genetic variants in the i ...... , node-positive breast cancer.
@ast
Host genetic variants in the i ...... , node-positive breast cancer.
@en
prefLabel
Host genetic variants in the i ...... , node-positive breast cancer.
@ast
Host genetic variants in the i ...... , node-positive breast cancer.
@en
P2093
P2860
P1433
P1476
Host genetic variants in the i ...... , node-positive breast cancer.
@en
P2093
Angela DeMichele
Jinbo Chen
Michelle Horn
Richard Aplenc
Robert Gray
William P Vaughan
P2860
P304
P356
10.1158/0008-5472.CAN-08-2989
P407
P577
2009-05-12T00:00:00Z